JP2012136518A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012136518A5 JP2012136518A5 JP2011280781A JP2011280781A JP2012136518A5 JP 2012136518 A5 JP2012136518 A5 JP 2012136518A5 JP 2011280781 A JP2011280781 A JP 2011280781A JP 2011280781 A JP2011280781 A JP 2011280781A JP 2012136518 A5 JP2012136518 A5 JP 2012136518A5
- Authority
- JP
- Japan
- Prior art keywords
- immunogenic composition
- lyophilized
- composition according
- lyophilized immunogenic
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061426476P | 2010-12-22 | 2010-12-22 | |
| US61/426,476 | 2010-12-22 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012136518A JP2012136518A (ja) | 2012-07-19 |
| JP2012136518A5 true JP2012136518A5 (https=) | 2015-01-29 |
| JP6097478B2 JP6097478B2 (ja) | 2017-03-15 |
Family
ID=45444677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011280781A Expired - Fee Related JP6097478B2 (ja) | 2010-12-22 | 2011-12-22 | 黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）抗原の安定な免疫原性組成物 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20130259896A1 (https=) |
| EP (2) | EP3150222B1 (https=) |
| JP (1) | JP6097478B2 (https=) |
| KR (2) | KR101808398B1 (https=) |
| CN (1) | CN103826656B (https=) |
| AU (1) | AU2011346535B2 (https=) |
| BR (1) | BR112013016153A2 (https=) |
| CA (1) | CA2819120C (https=) |
| DK (2) | DK2654784T3 (https=) |
| ES (2) | ES2614815T3 (https=) |
| HU (2) | HUE047263T2 (https=) |
| IL (1) | IL226793B (https=) |
| MX (1) | MX350170B (https=) |
| PL (2) | PL3150222T3 (https=) |
| PT (2) | PT2654784T (https=) |
| RU (1) | RU2570730C2 (https=) |
| SI (2) | SI2654784T1 (https=) |
| WO (1) | WO2012085872A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070058631A (ko) | 2004-09-22 | 2007-06-08 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 면역원성 조성물 |
| BRPI1011753B8 (pt) | 2009-06-22 | 2021-05-25 | Wyeth Llc | conjugados imunogênicos de polissacarídeo capsular de staphylococcus aureus de sorotipos 5 e 8, seu uso e composições que os compreendem |
| HUE036372T2 (hu) | 2009-06-22 | 2018-07-30 | Wyeth Llc | Staphylococcus aureus antigének immunogén készítményei |
| PT2575870T (pt) * | 2010-06-04 | 2017-02-10 | Wyeth Llc | Formulações de vacinas |
| US9789176B2 (en) * | 2011-03-16 | 2017-10-17 | Regents Of The University Of Minnesota | Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus |
| GB201310008D0 (en) * | 2013-06-05 | 2013-07-17 | Glaxosmithkline Biolog Sa | Immunogenic composition for use in therapy |
| AU2014359277B2 (en) * | 2013-12-04 | 2017-10-26 | Glaxosmithkline Biologicals S.A. | Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli |
| IL310015B2 (en) | 2013-12-31 | 2026-02-01 | Access To Advanced Health Inst | Single vial formulation |
| PL3129001T3 (pl) * | 2014-04-10 | 2020-06-29 | Asit Biotech S.A. | Preparat alergenów wolny od hsp |
| CN110996992A (zh) * | 2017-08-16 | 2020-04-10 | 默沙东公司 | 肺炎球菌缀合物疫苗制剂 |
| GB201802339D0 (en) | 2018-02-13 | 2018-03-28 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| KR102649069B1 (ko) | 2018-05-31 | 2024-03-19 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 안면 홍조 개선용 조성물 |
| JP7079984B2 (ja) * | 2018-07-28 | 2022-06-03 | エクソコバイオ インコーポレイテッド | エキソソームの凍結乾燥方法 |
| KR102163806B1 (ko) | 2018-07-30 | 2020-10-07 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물 |
| JP2023512446A (ja) * | 2020-01-13 | 2023-03-27 | アプティーボ リサーチ アンド デベロップメント エルエルシー | 治療的タンパク質の薬物送達システム構成要素への吸着を防ぐ方法および組成物 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4902506A (en) | 1983-07-05 | 1990-02-20 | The University Of Rochester | Immunogenic conjugates |
| US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
| US4708871A (en) | 1983-03-08 | 1987-11-24 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| SE8405493D0 (sv) | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
| US5078996A (en) | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| HU212924B (en) | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
| IT1253009B (it) | 1991-12-31 | 1995-07-10 | Sclavo Ricerca S R L | Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini |
| US5571515A (en) | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6008341A (en) | 1994-08-22 | 1999-12-28 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | S. aureus fibrinogen binding protein gene |
| BE1008978A5 (fr) | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
| JPH11514870A (ja) | 1995-10-16 | 1999-12-21 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 新規な唾液結合タンパク質 |
| GB9622159D0 (en) | 1996-10-24 | 1996-12-18 | Solvay Sociutu Anonyme | Polyanionic polymers as adjuvants for mucosal immunization |
| GB9622660D0 (en) | 1996-10-31 | 1997-01-08 | Biocine Spa | Immunogenic detoxified mutant toxin |
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| AU1537699A (en) | 1997-11-26 | 1999-06-15 | Bioresearch Ireland a division of Eolas - The Irish Science and Technology Agency | Extracellular matrix-binding proteins from (staphylococcus aureus) |
| US6680195B1 (en) | 1997-11-26 | 2004-01-20 | Inhibitex, Inc. | Extracellular matrix-binding proteins from staphylococcus aureus |
| KR100644953B1 (ko) * | 1998-08-31 | 2006-11-10 | 인히비텍스, 인코포레이티드 | 다성분 백신 |
| US6936258B1 (en) | 1999-03-19 | 2005-08-30 | Nabi Biopharmaceuticals | Staphylococcus antigen and vaccine |
| US7115730B1 (en) | 1999-04-27 | 2006-10-03 | Chiron Srl | Immunogenic detoxified mutant E. coli LT-A-toxin |
| US7384640B1 (en) | 1999-09-30 | 2008-06-10 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant |
| AU2001281812B2 (en) | 2000-06-08 | 2005-04-07 | Valneva Austria Gmbh | Immunostimulatory oligodeoxynucleotides |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| CA2449670A1 (en) | 2001-06-07 | 2002-12-12 | Wyeth Holdings Corporation | Mutant forms of cholera holotoxin as an adjuvant |
| KR100898648B1 (ko) | 2001-06-07 | 2009-05-22 | 와이어쓰 홀딩스 코포레이션 | 보조제로서 콜레라 홀로톡신의 돌연변이체 형태 |
| JP4424984B2 (ja) | 2001-06-15 | 2010-03-03 | インヒビテックス インコーポレーテッド | コアグラーゼ陰性ブドウ球菌および黄色ブドウ球菌由来の表面蛋白質を認識する、交差反応性モノクローナルおよびポリクローナル抗体 |
| GB0118249D0 (en) * | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| BRPI0408167B1 (pt) | 2003-03-07 | 2014-10-21 | Wyeth Corp | Conjugados de polissacarídeo-proteína veículo adesina da superfície estafilocócica para imunização contra infecções nosocomiais |
| US20060251675A1 (en) | 2003-03-17 | 2006-11-09 | Michael Hagen | Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
| GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
| KR20070058631A (ko) | 2004-09-22 | 2007-06-08 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 면역원성 조성물 |
| MY148405A (en) * | 2006-03-30 | 2013-04-30 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| GB0606416D0 (en) * | 2006-03-30 | 2006-05-10 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| AR060187A1 (es) * | 2006-03-30 | 2008-05-28 | Glaxosmithkline Biolog Sa | Composicion inmunogenica |
| WO2007127668A2 (en) | 2006-04-26 | 2007-11-08 | Wyeth | Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations |
| CL2007003209A1 (es) * | 2006-11-07 | 2008-05-09 | Acambis Inc | Composicion que comprende una vacuna de flavivirus vivos atenuados; composicion que comprende un producto farmaceutico derivado de virus o proteina; un metodo para la elaboracion de una composicion terapeutica que comprende liofilizar las composicion |
| ES2615390T3 (es) | 2008-03-05 | 2017-06-06 | Sanofi Pasteur | Proceso para estabilizar una composición de vacuna que contiene adyuvante |
| HUE036372T2 (hu) * | 2009-06-22 | 2018-07-30 | Wyeth Llc | Staphylococcus aureus antigének immunogén készítményei |
-
2011
- 2011-12-21 DK DK11804822.2T patent/DK2654784T3/en active
- 2011-12-21 KR KR1020157031951A patent/KR101808398B1/ko not_active Expired - Fee Related
- 2011-12-21 PT PT118048222T patent/PT2654784T/pt unknown
- 2011-12-21 KR KR1020137018851A patent/KR20130114210A/ko not_active Ceased
- 2011-12-21 CN CN201180068105.5A patent/CN103826656B/zh not_active Expired - Fee Related
- 2011-12-21 ES ES11804822.2T patent/ES2614815T3/es active Active
- 2011-12-21 RU RU2013128277/15A patent/RU2570730C2/ru active IP Right Revival
- 2011-12-21 WO PCT/IB2011/055883 patent/WO2012085872A2/en not_active Ceased
- 2011-12-21 US US13/993,887 patent/US20130259896A1/en not_active Abandoned
- 2011-12-21 ES ES16193095T patent/ES2769425T3/es active Active
- 2011-12-21 CA CA2819120A patent/CA2819120C/en active Active
- 2011-12-21 HU HUE16193095A patent/HUE047263T2/hu unknown
- 2011-12-21 PL PL16193095T patent/PL3150222T3/pl unknown
- 2011-12-21 AU AU2011346535A patent/AU2011346535B2/en not_active Ceased
- 2011-12-21 HU HUE11804822A patent/HUE033072T2/hu unknown
- 2011-12-21 SI SI201131064A patent/SI2654784T1/sl unknown
- 2011-12-21 SI SI201131825T patent/SI3150222T1/sl unknown
- 2011-12-21 EP EP16193095.3A patent/EP3150222B1/en active Active
- 2011-12-21 PT PT161930953T patent/PT3150222T/pt unknown
- 2011-12-21 PL PL11804822T patent/PL2654784T3/pl unknown
- 2011-12-21 EP EP11804822.2A patent/EP2654784B1/en active Active
- 2011-12-21 MX MX2013006960A patent/MX350170B/es active IP Right Grant
- 2011-12-21 DK DK16193095.3T patent/DK3150222T3/da active
- 2011-12-21 BR BR112013016153A patent/BR112013016153A2/pt not_active Application Discontinuation
- 2011-12-22 JP JP2011280781A patent/JP6097478B2/ja not_active Expired - Fee Related
-
2013
- 2013-06-06 IL IL226793A patent/IL226793B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012136518A5 (https=) | ||
| RU2013128277A (ru) | СТАБИЛЬНЫЕ ИММУНОГЕННЫЕ КОМПОЗИЦИИ АНТИГЕНОВ Staphylococcus aureus | |
| HRP20211417T1 (hr) | Formulacije koje stabiliziraju i sprječavaju taloženje imunogenih pripravaka | |
| JP2016520075A5 (https=) | ||
| JP2014530010A5 (https=) | ||
| PH12017500844A1 (en) | Stable protein solution formulation containing high concentration of an anti-vegf antibody | |
| JP2012515221A5 (https=) | ||
| JP2013543505A5 (https=) | ||
| RU2017104529A (ru) | Композиции neisseria meningitidis и способы их применения | |
| WO2007130493A3 (en) | Cd40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity | |
| PE20121517A1 (es) | Compuestos lipopeptidos y metodos relacionados | |
| HRP20160276T1 (hr) | Pripravci za imuniziranje protiv bakterije staphylococcus aureus | |
| RU2017101667A (ru) | Фармацевтические композиции | |
| JP2015231997A5 (https=) | ||
| HRP20201268T1 (hr) | Stabilne formulacije koje sadrže anti-pcsk9 antitijela | |
| HRP20210242T1 (hr) | Stabilne formulacije antigena iz bakterije neisseria meningitidis rlp2086 | |
| JP2014040441A5 (https=) | ||
| HRP20160434T1 (hr) | Formulacija abeta-protutijela | |
| JP2011528222A5 (https=) | ||
| WO2007095318A3 (en) | Influenza antigens, vaccine compositions, and related methods | |
| RU2015122368A (ru) | Слитые белки для применения в качестве иммуногенных усиливающих агентов для индуцирования антигенспецифического т-клеточного ответа | |
| EA201490804A1 (ru) | Препараты этанерцепта, стабилизированные хлоридом натрия | |
| NO20090177L (no) | Vaksiner for malaria | |
| EA200870264A1 (ru) | Композиция антител | |
| FI3725330T3 (fi) | Polypeptidien stabiilit valmisteet ja niiden käyttötarkoitukset |